| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 3.4 | 4.3 | 7.0 |
| Other income | 5.6 | 0.8 | 2.1 |
| Total income | 9.0 | 5.1 | 9.1 |
| Profit before exceptional items & tax | 3.0 | -0.7 | 1.4 |
| Profit before tax | 3.0 | -0.7 | 1.4 |
| Net profit | 3.0 | -0.8 | 1.7 |
| Operating margin | 33.3% | -13.7% | 15.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +76.50% |
|---|---|
| Revenue, year on year | -51.40% |
BSE results filing, BSE: 523144. Figures extracted from the filing.
Medi Caps Ltd: key numbers
- Share price
- ₹25.42
- Market cap
- ₹31.70 Cr
- Revenue (annual)
- ₹12.45 Cr
- Net profit (annual)
- ₹-3.04 Cr
- P/E (TTM)
- -17.8×Sector 50.4×
- Promoter holding
- 51.44%+0.08% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medi Caps Ltd
All →Medi-caps Management Change
Medi-Caps Limited has re-appointed Alok K Garg as Executive Director and appointed Saloni Garg as an additional Executive Director for a 36-month term.
Medi Caps Annual General Meeting
Medi-Caps Limited held its 43rd Annual General Meeting on September 22, 2026. The meeting proceedings covered financial adoption and director appointments.
Medi Caps Q1 FY27 Results: Net Loss of ₹2.2 Cr, Loss Narrows
Medi Caps Ltd reported revenue from operations of ₹2.8 Cr (+3.7% YoY) and a net loss of ₹2.2 Cr for Q1 FY27.
- Key figure
- Net loss ₹2.2 Cr